LLY

747.85

-0.07%↓

UNH

590.82

-1.04%↓

JNJ

155.2

-0.15%↓

NVO

105.18

+2.52%↑

ABBV

177.14

+3.17%↑

LLY

747.85

-0.07%↓

UNH

590.82

-1.04%↓

JNJ

155.2

-0.15%↓

NVO

105.18

+2.52%↑

ABBV

177.14

+3.17%↑

LLY

747.85

-0.07%↓

UNH

590.82

-1.04%↓

JNJ

155.2

-0.15%↓

NVO

105.18

+2.52%↑

ABBV

177.14

+3.17%↑

LLY

747.85

-0.07%↓

UNH

590.82

-1.04%↓

JNJ

155.2

-0.15%↓

NVO

105.18

+2.52%↑

ABBV

177.14

+3.17%↑

LLY

747.85

-0.07%↓

UNH

590.82

-1.04%↓

JNJ

155.2

-0.15%↓

NVO

105.18

+2.52%↑

ABBV

177.14

+3.17%↑

Search

AstraZeneca PLC ADR

Closed

65.65 2.08

Overview

Share price change

24h

Current

Min

65.56

Max

65.7

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+33.58 upside

Technical Score

By Trading Central

Confidence

Strong Bullish Evidence

AstraZeneca PLC ADR Chart

Past performance is not a reliable indicator of future results.

Related News

١٢ نوفمبر ٢٠٢٤، ٠٧:٥٥ م UTC

Earnings

AstraZeneca Expands U.S. Investment Plan -- 3rd Update

١٢ نوفمبر ٢٠٢٤، ١١:٠٢ ص UTC

Earnings

AstraZeneca Raises Outlook, Plans U.S. Investment -- Update

١٢ نوفمبر ٢٠٢٤، ٠٧:٣٧ ص UTC

Earnings

AstraZeneca Raises Outlook on Earnings, Sales Beat

١٠ سبتمبر ٢٠٢٤، ٠٩:٢٩ ص UTC

Major Market Movers

AstraZeneca Shares Slump After Cancer Drug Misses Key Target

١٨ نوفمبر ٢٠٢٤، ١٠:٣٣ ص UTC

Market Talk

Pharmaceutical Sector Outlook for 2025 Looks Rocky -- Market Talk

١٥ نوفمبر ٢٠٢٤، ٠١:٠٨ م UTC

Top News

Trump's RFK Pick Weighs on Vaccine Makers -- WSJ

١٥ نوفمبر ٢٠٢٤، ١٠:٢٩ ص UTC

Hot Stocks

Stocks to Watch Friday: Tesla, Domino's, Palantir, Ulta -- WSJ

١٢ نوفمبر ٢٠٢٤، ٠٣:٣٠ م UTC

Top News

AstraZeneca Expands U.S. Investment Plan -- 2nd Update

١٢ نوفمبر ٢٠٢٤، ٠١:٣٩ م UTC

Market Talk

AstraZeneca's Results Make $80B Revenue Target Look Achievable -- Market Talk

١٢ نوفمبر ٢٠٢٤، ١٠:٤٩ ص UTC

Market Talk
Earnings

AstraZeneca Seen With Positive Momentum at Pivotal Period -- Market Talk

١٢ نوفمبر ٢٠٢٤، ٠٩:٥٢ ص UTC

Market Talk

AstraZeneca's New Guidance Could Imply Consensus Upgrades -- Market Talk

١٢ نوفمبر ٢٠٢٤، ٠٧:٠٢ ص UTC

Earnings

AstraZeneca Had Seen 2024 Core EPS Growth by Mid Teens Percentage Range

١٢ نوفمبر ٢٠٢٤، ٠٧:٠٢ ص UTC

Earnings

AstraZeneca Sees 2024 Core EPS Growth In High Teens Percentage Range

١٢ نوفمبر ٢٠٢٤، ٠٧:٠٢ ص UTC

Earnings

AstraZeneca Had Seen 2024 Total Revenue Growth In Mid Teens Percentage Range

١٢ نوفمبر ٢٠٢٤، ٠٧:٠٢ ص UTC

Earnings

AstraZeneca Sees 2024 Total Revenue Growth In High Teens Percentage Range

١٢ نوفمبر ٢٠٢٤، ٠٧:٠٢ ص UTC

Earnings

AstraZeneca Raises 2024 View

١٢ نوفمبر ٢٠٢٤، ٠٧:٠١ ص UTC

Earnings

Analysts Saw AstraZeneca 3Q Sales at $13.1B

١٢ نوفمبر ٢٠٢٤، ٠٧:٠١ ص UTC

Earnings

Analysts Saw AstraZeneca 3Q Core EPS at $2.04

١٢ نوفمبر ٢٠٢٤، ٠٧:٠٠ ص UTC

Earnings

AstraZeneca PLC 3Q EPS 91c

١٢ نوفمبر ٢٠٢٤، ٠٧:٠٠ ص UTC

Earnings

AstraZeneca PLC 3Q Net Pft $1.43B

١٢ نوفمبر ٢٠٢٤، ٠٧:٠٠ ص UTC

Earnings

AstraZeneca PLC 3Q Oper Pft $2.11B

٧ نوفمبر ٢٠٢٤، ٠٨:٠٣ ص UTC

Top News

China Has Detained a Senior AstraZeneca Executive -- Update

٦ نوفمبر ٢٠٢٤، ٠٦:٥٥ م UTC

Top News

China Has Detained Senior AstraZeneca Executive -- WSJ

١ نوفمبر ٢٠٢٤، ٠٣:٠٠ ص UTC

Top News

U.S. Drugmakers Are Breaking Up With Their Chinese Supply-Chain Partners -- WSJ

٣١ أكتوبر ٢٠٢٤، ٠٧:٤٨ م UTC

Top News

AstraZeneca Probe in China Adds to Concerns for Foreign Businesses -- Update

٣١ أكتوبر ٢٠٢٤، ٠٢:٤٣ م UTC

Top News

AstraZeneca Probe in China Adds to Concerns for Foreign Businesses -- WSJ

١٢ سبتمبر ٢٠٢٤، ٠٥:٠١ م UTC

Top News

The Brawl Taking Shape Over Pfizer's Multibillion-Dollar Heart Monopoly -- Heard on the Street -- Update

١٢ سبتمبر ٢٠٢٤، ١١:٠٠ ص UTC

Top News

The Brawl Taking Shape Over Pfizer's Multibillion-Dollar Heart Monopoly -- Heard on the Street -- WSJ

١٠ سبتمبر ٢٠٢٤، ٠١:٠٨ م UTC

Market Talk

AstraZeneca's Lung Cancer Drug Candidate Disappoints, Lowering Probability of FDA Approval -- Market Talk

٩ سبتمبر ٢٠٢٤، ٠٧:٥٦ ص UTC

Market Talk

Big Pharma's Stability in Return on R&D Investment Is Encouraging -- Market Talk

Peer Comparison

Price change

AstraZeneca PLC ADR Forecast

Price Target

By TipRanks

33.58% upside

12 Months Forecast

Average 87.67 USD  33.58%

High 88 USD

Low 87 USD

Based on 6 Wall Street analysts offering 12 month price targets forAstraZeneca PLC ADR - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

6 ratings

5

Buy

1

Hold

0

Sell

Technical Score

By Trading Central

64.27 / 65.98Support & Resistance

Short Term

Strong Bullish Evidence

Intermediate Term

Strong Bearish Evidence

Long Term

Bearish Evidence

Financials

$